Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter changes: the HHS Vulnerability Disclosure link was removed and the Revision: v3.3.3 tag was added. These changes are limited to footer and metadata and do not affect the study content.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.3.2 is shown, replacing the previous v3.3.1. This appears to be a minor frontend update that does not alter study details or functionality.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded clarifications that publications are provided voluntarily and are automatically filled from PubMed, and noted Revision: v3.3.1. The prior language implying PubMed articles are automatically generated and may relate to the study results was removed.SummaryDifference0.2%

- Check58 days agoChange DetectedRemoval of the government funding status notice at the bottom of the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments with no updates to core trial data (title, conditions, interventions, eligibility criteria, primary outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check100 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.